Overview

Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution

Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and tolerability profile of a dwell time (bath) of 24 hours using a 500 ml sodium-free peritoneal dialysis solution based on 30% icodextrin and 10% dextrose in patients with chronic kidney failure undergoing peritoneal dialysis
Phase:
Phase 1
Details
Lead Sponsor:
Instituto Mexicano del Seguro Social
Collaborator:
Sequana Medical
Treatments:
Icodextrin